Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GUSTA: Maraviroc + Darunavir/r Switch in HIV
NCT01367210Phase 4Terminated
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Jun 2011
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of maraviroc, darunavir in human immunodeficiency virus infection (HIV), sponsored by Università Cattolica del Sacro Cuore. Started Jun 2011; status: terminated.
02
Drugs
maravirocdarunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01367210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01367210.